Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " February 20, 2008":" March 21, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
Condition: HIV Infection
Intervention: Drug: Tenofovir + emtricitabine + raltegravir.
22 Completed Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting
Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting;   HIV Infections
Interventions: Drug: Dronabinol;   Drug: Placebo
23 Completed Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Conditions: Pregnancy;   HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: CenteringPregnancy Plus (CP+);   Behavioral: Usual care
24 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
25 Completed Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts
Conditions: HIV Infections;   Protozoan Infections
Intervention: Genetic: amoeba
26 Completed Yoga for the Management of HIV-Metabolic Syndromes
Conditions: HIV Infections;   HIV Metabolic Cardiovascular Syndrome;   HIV Lipodystrophy;   HIV Metabolic Syndromes;   Hypertension
Interventions: Behavioral: Yoga lifestyle intervention;   Other: Standard of care
27 Completed Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis
Condition: Oral Candidiasis
Intervention: Drug: PAC113
28 Completed
Has Results
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
Conditions: HIV Infections;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
29 Completed
Has Results
Exercise and Pioglitazone for HIV-Metabolic Syndromes
Conditions: HIV Infections;   Type 2 Diabetes;   Obesity;   HIV;   AIDS;   Cardiovascular Disease;   Lipodystrophy
Interventions: Drug: Pioglitazone;   Behavioral: Exercise training
30 Completed Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Conditions: Allergic Rhinitis;   Asthma;   Back Pain;   Benign Prostatic Hypertrophy;   Bursitis;   Depression;   Anxiety;   Diabetes Mellitus;   Esophageal Reflux;   HIV Infections;   Hyperlipidemia;   Hypertension;   Insomnia;   Irritable Bowel Syndrome;   Obesity;   Osteoporosis (Senile);   Shoulder Pain;   Sinusitis;   Symptomatic Menopause;   Urinary Incontinence;   Urinary Tract Infection;   Vaginitis
Intervention: Other: Health Information Prescription
31 Withdrawn Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)
Condition: Pneumocystis Carinii Pneumonia
Interventions: Drug: Antibiotics only;   Drug: Antibiotics + Corticosteroids;   Drug: Corticosteroids + antibiotics
32 Active, not recruiting Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Condition: Lymphoma
Interventions: Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Other: pharmacological study;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Study has passed its completion date and status has not been verified in more than two years.